Denitsa received B.S. in Mechanical Eng. from University of Central Florida, and M.S. and Ph.D. in Mechanical Eng. from Stanford University. Denitsa also holds a M.Sc. in Management from Stanford’s Graduate School of Business. At the lab of George Church, Denitsa works on a platform technology for genetic engineering of skin. Broadly, her research focus includes skin gene therapies which enable resistance to carcinogenic insults, enhanced mechanical properties, barrier function and regeneration capacity for cellular rejuvenation. In addition, Denitsa works on engineering skin tissues to acquire capabilities for passive production of biologics such as exogenous antibodies (as in vaccines) to modulate humans’ immunity and susceptibility to infections and disease.